We will leverage our forward-thinking creativity and technological capabilities to contribute to the future of life sciences.
Sogo Yakuco started as an active pharmaceutical ingredient manufacturer producing substances such as Sulfisozine, Sulfadimethoxine, and Taurine. Leveraging the synthetic technologies acquired through active pharmaceutical ingredients, we engage in the development and manufacturing of functional cosmetic ingredients, recording materials, and electronic materials. With the keywords "safety," "technical capability," "speed," "quality," and "environment," we strive to meet the needs of the life sciences sector with a spirit of "challenge" and continuous corporate efforts. 【Business Activities】 ■ Manufacturing, sales, and import/export of pharmaceutical active ingredients, veterinary pharmaceuticals, and functional cosmetic ingredients ■ Manufacturing, sales, and import/export of fine chemical products such as specialty chemicals and chemical industrial products *For more details, please refer to the PDF materials or feel free to contact us.
Inquire About This Product
basic information
【Products Handled】 ■ Pharmaceutical Raw Materials - Chlorhexidine hydrochloride - Felbinac ■ Cosmetic Ingredients - Hypotaurine - Thiotaurine - Pantetheine-S-sulfonic acid calcium ■ Intermediates - Cysteamine - Thiazolidine - 2-Methyl-2-thiazoline - ZWT-03 - Bunte salt - Trichloroacetonitrile - 1AE2MI - Isophthalic acid monomethyl ■ Specialty Chemicals - CROSSLINKER CL-427 - BIA *For more details, please refer to the PDF document or feel free to contact us.
Price range
Delivery Time
Applications/Examples of results
For more details, please refer to the PDF document or feel free to contact us.
catalog（1）
Download All Catalogs
Company information
Our company started as an active pharmaceutical ingredient manufacturer producing substances such as Sulfisozole, Sulfadimethoxine, and Taurine. Furthermore, we have expanded into new products such as Chlorhexidine Hydrochloride, Indomethacin, and steroid active pharmaceutical ingredients, while also focusing on the synthesis of pharmaceutical intermediates, thereby establishing our position as a manufacturer of active pharmaceutical ingredients and intermediates. Additionally, leveraging the synthetic technologies acquired through our active pharmaceutical ingredients, we are engaged in the development and manufacturing of functional cosmetic ingredients, recording materials, and electronic materials.
![[Technology and Achievements Introduction] Absorption Improvement Technology (Nanosized Formulation)](https://image.mono.ipros.com/public/product/image/ce6/2000706996/IPROS80210347929226024498.png?w=280&h=280)
![[CPhI Seminar Report] Mutagenic Impurities in Pharmaceuticals (Active Pharmaceutical Ingredients)](https://image.mono.ipros.com/public/product/image/86f/2000714763/IPROS54094091646706511898.png?w=280&h=280)
![[Column] Management Strategies for Starting Materials in Active Pharmaceutical Ingredients](https://image.mono.ipros.com/public/product/image/3e5/2000710289/IPROS06292587954207697823.png?w=280&h=280)
![[Demo Available] Mixed Gas for Hydrogen Cutting "Hydrocut 60・90"](https://image.mono.ipros.com/public/product/image/2e0/2000168848/IPROS17938586379387792278.jpg?w=280&h=280)
